Skip to main content

Does moclobemide stimulate melatonin synthesis as the other selective MAO-A inhibitors do?

  • Conference paper
Book cover Amine Oxidases and Their Impact on Neurobiology

Part of the book series: Journal of Neural Transmission ((NEURAL SUPPL,volume 32))

  • 98 Accesses

Summary

It has been reported that selective MAO-A inhibitors, clorgyline and brofaromine, but not the MAO-B inhibitors, deprenyl and pargyline, stimulated rat pineal melatonin synthesis in humans and animals. Recent studies, however, found no eflect of moclobemide, a selective MAO-A inhibitor, on human plasma melatonin levels.

Present study found that in vitro moclobemide produced very weak stimulation of rat pineal NAT activity. However, in vivo moclobemide induced a significant increase of rat pineal NAS and melatonin content, and a dramatic decrease of 5-HIAA content (HPLC-fluorimetric procedure). Moclobemide’s effect on melatonin and related indoles could be detected as early as 30 min after the injection and lasted, at least, for 2 h.

The possible reasons for discrepancies between human and animal data are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Bieck PR, Antonin KH, Balon R, Oxenkrug GF (1988) Brofaromine and pargyline effect on human plasma melatonin. Prog Neuropsychopharmacol Biol Psychiatry 12:93–101.

    Article  PubMed  CAS  Google Scholar 

  • Bieck PR, Muhlbauer B, Antonin KH (1989) Differential effects of brofaromine and moclobemide on melatonin secretion. In: Stefanis CN, Soldatos CR, Rabavilas AD (eds) Psychiatry today. Abstracts of the 7th World Congress of Psychiatry, Athens, 1989. Excerpta Medica, International Congress Series 899, p 503, abstract 1946.

    Google Scholar 

  • Da Prada M, Kettler R, Keller HH, Burkard W, Muggli-Maniglio D, Haefely WE (1989) Neurochemical profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A. J Pharmacol Exp Ther 248:400–414.

    PubMed  Google Scholar 

  • Golden RN, Markey SP, Risby ED, Rudorfer MV, Cowdry RW, Potter WZ (1988) Antidepressants reduce whole-body norepinephrine turnover while enhancing 6-hydroxymelatonin output. Arch Gen Psychiatry 45:150–154.

    Article  PubMed  CAS  Google Scholar 

  • Murphy DL, Tamarkin L, Sunderland T, Garrick NA, Cohen R (1986) Human plasma melatonin is elevated during treatment with the monoamine oxidase inhibitors clorgyline and tranylcypromine but not deprenyl. Psychiatry Res 17:119–127.

    Article  PubMed  CAS  Google Scholar 

  • Oxenkrug G, McCauley R, McIntyre I, Filipowicz C (1984) Effect of clorgyline and deprenyl on rat pineal melatonin. J Pharm Pharmacol 36:55W.

    Google Scholar 

  • Oxenkrug G, Mclntyre I, McCauley R, Filipowicz C (1985) Selective inhibition of MAO-A but not MAO-B activity increases rat pineal melatonin. J Neural Transm 61:265–270.

    Article  PubMed  CAS  Google Scholar 

  • Oxenkrug GF, Balon R, Jain AK, Mclntyre IM, Appel D (1986a) Single dose of tranylcypromine increases human plasma melatonin. Biol Psychiatry 21:1085–1089.

    Article  PubMed  CAS  Google Scholar 

  • Oxenkrug GF, McCauley RB, Fontana DJ, Mclntyre IM, Commissaris RL (1986b) Possible melatonin involvement in the hypotensive effect of MAO inhibitors. J Neural Transm 66:271–280.

    Article  PubMed  CAS  Google Scholar 

  • Oxenkrug G, Mclntyre I, McCauley R, Yuwiler A (1988) The effect of selective MAO inhibitors on rat pineal melatonin synthesis in vitro. J Pineal Res 5:99–109.

    Article  PubMed  CAS  Google Scholar 

  • Oxenkrug GF (1990) The acute effect of monoamine oxidase inhibitors on serotonin conversion to melatonin. In: Sandier M, Coppen A, Harnett S (eds) 5-Hydroxytryptamine in psychiatry: spectrum of ideas. Oxford University Press, pp 98-109.

    Google Scholar 

  • Scheinin M, Koulu M, Vakkuri O, Vuorinen J, Zimmer H (1990) Moclobemide, an inhibitor of MAO-A, does not increase daytime melatonin levels in normal humans. Prog Neuropsychopharmacol Biol Psychiatry 14:73–82.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer-Verlag

About this paper

Cite this paper

Oxenkrug, G.F., Requintina, P.J., Yuwiler, A. (1990). Does moclobemide stimulate melatonin synthesis as the other selective MAO-A inhibitors do?. In: Riederer, P., Youdim, M.B.H. (eds) Amine Oxidases and Their Impact on Neurobiology. Journal of Neural Transmission, vol 32. Springer, Vienna. https://doi.org/10.1007/978-3-7091-9113-2_25

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-9113-2_25

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-82239-5

  • Online ISBN: 978-3-7091-9113-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics